Bromide

Bromide

SCHEMBL15510433

Br.Br.O=[PH](ON1CCOCC1)ON1CCOCC1

nearest known ligand 0.33

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3APH1AAPH1BCHRM2CHRM3EZH2GRIN2AHTR1AHTR1BHTR1DHTR1FHTR3ANCSTNP2RY12PSEN1PSEN2PSENENSIGMAR1SLC6A2SLC6A3SLC6A4

The experimentally established mechanism targets of Bromide. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
▸ CA12 O43570 2/20 0.33
▸ CA7 P43166 1/20 0.33
▸ CA14 Q9ULX7 1/20 0.33
▸ L3MBTL1 Q9Y468 1/20 0.31
▸ MGLL Q99685 1/20 0.31
▸ SMN1; SMN2 Q16637 1/20 0.30
▸ CA1 P00915 1/20 0.30
▸ CA9 Q16790 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4921164 0.97 CA12 (0.35) CA12CA7CA14L3MBTL1MGLL
Hydrochloric Acid SCHEMBL15511220 0.95 CA12 (0.33) CA12CA7CA14L3MBTL1MGLL
SCHEMBL5963920 0.84 ALDH1A1 (0.32) CA12CA7CA14SMN1; SMN2
SCHEMBL4921168 0.78 L3MBTL1 (0.34) CA12CA7CA14L3MBTL1SMN1; SMN2
SCHEMBL28171149 0.78 CA12 (0.34) CA12CA7CA14L3MBTL1SMN1; SMN2
SCHEMBL28171228 0.78 SMN1; SMN2 (0.39) CA12L3MBTL1SMN1; SMN2CA1CA9
SCHEMBL15570949 0.76 L3MBTL1 (0.33) CA12CA7CA14L3MBTL1SMN1; SMN2
SCHEMBL15572514 0.76 L3MBTL1 (0.33) CA12CA7CA14L3MBTL1SMN1; SMN2
SCHEMBL15571536 0.76 L3MBTL1 (0.33) CA12CA7CA14L3MBTL1SMN1; SMN2
SCHEMBL15572885 0.76 L3MBTL1 (0.33) CA12CA7CA14L3MBTL1SMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150202607-A1 POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS Midori Renewables, Inc. (US) 2015-07-23 — — US claimed
US-20230255240-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF MIDORI USA, INC. 2023-08-17 — — US disclosed
EP-4209130-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF DSM Nutritional Products, LLC (US) 2023-07-12 — — EP disclosed
EP-4205553-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF DSM Nutritional Products, LLC (US) 2023-07-05 — — EP disclosed
US-11653676-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof DSM NUTRITIONAL PRODUCTS, LLC (US) 2023-05-23 — — US disclosed
US-11584805-B2 Oligosaccharide compositions and methods for producing thereof DSM NUTRITIONAL PRODUCTS, LLC (US) 2023-02-21 — — US disclosed
US-20220409644-A1 ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE DSM NUTRITIONAL PRODUCTS, LLC 2022-12-29 — — US disclosed
US-20220400728-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF CADENA BIO INC (US) 2022-12-22 — — US disclosed
US-20210352945-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF HERCULES CAPITAL, INC. 2021-11-18 — — US disclosed
US-20210121486-A1 ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE HERCULES CAPITAL, INC. 2021-04-29 — — US disclosed
US-20160366909-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF MIDORI USA, INC. (US) 2016-12-22 — — US disclosed
WO-2016122887-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE ANIMAL FEED AND METHODS OF PRODUCING THEREOF MIDORI USA, INC. (US) 2016-08-04 — — WO disclosed
WO-2016122940-A1 METHODS OF PRODUCING ANHYDROSUGAR ALCOHOLS MIDORI USA, INC. (US) 2016-08-04 — — WO disclosed
WO-2016122885-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF MIDORI USA, INC. (US) 2016-08-04 — — WO disclosed
WO-2016122884-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS FOOD INGREDIENTS AND METHODS OF PRODUCING THEREOF MIDORI USA, INC. (US) 2016-08-04 — — WO disclosed
US-9238845-B2 Methods of producing sugars from biomass feedstocks MIDORI USA, INC. (US) 2016-01-19 — — US disclosed
US-20160007642-A1 OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF MIDORI USA, INC. (US) 2016-01-14 — — US disclosed
WO-2016007778-A1 OLIGOSACCHARIDE COMPOSITIONS AND METHODS FOR PRODUCING THEREOF MIDORI USA, INC. (US) 2016-01-14 — — WO disclosed
US-20150202607-A1 POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS Midori Renewables, Inc. (US) 2015-07-23 — — US disclosed
US-20140060522-A1 METHODS OF PRODUCING SUGARS FROM BIOMASS FEEDSTOCKS HERCULES CAPITAL, INC. 2014-03-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (8 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230255240-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF FUT5, FUT6, OSTC CA12 749/4885CA7 927/4885CA14 337/4885
US-11584805-B2 Oligosaccharide compositions and methods for producing thereof OSTC, FUT5, FUT6 CA12 90/4885CA7 122/4885CA14 61/4885
US-11653676-B2 Oligosaccharide compositions for use as animal feed and methods of producing thereof FUT5, FUT6, OSTC CA12 749/4885CA7 927/4885CA14 337/4885
US-20220409644-A1 ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE FUT6, FUT5, PIGS CA12 827/4885CA7 1767/4885CA14 899/4885
US-20210352945-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE IN NUTRITIONAL COMPOSITIONS, AND METHODS OF PRODUCING THEREOF OSTC, FUT5, FUT6 CA12 940/4885CA7 822/4885CA14 599/4885
US-20160366909-A1 OLIGOSACCHARIDE COMPOSITIONS FOR USE AS ANIMAL FEED AND METHODS OF PRODUCING THEREOF FUT5, FUT6, OSTC CA12 749/4885CA7 927/4885CA14 337/4885
US-20210121486-A1 ANIMAL THERAPEUTIC AND FEED COMPOSITIONS AND METHODS OF USE FUT6, FUT5, PIGS CA12 827/4885CA7 1767/4885CA14 899/4885
US-20150202607-A1 POLYMERIC AND SOLID-SUPPORTED CATALYSTS, AND METHODS OF DIGESTING CELLULOSIC MATERIALS USING SUCH CATALYSTS MGAM, CEL, SI CA12 80/4885CA7 94/4885CA14 39/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback